Rinvoq ER 30 MG tablet UU 30S

Ended Awarded Last action

Contract number
SPE2DR26F92MN
Awardee
Awarding agency
Obligated
$57,487

Award facts

Contract value 100% obligated
$57,487.07 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on May 11, 2026, with a ceiling value of $57,487.07 for RINVOQ ER 30 MG tablets (30-tablet units).

Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of May 12, 2026. This delivery order is issued under the DLA Troop Support Medical indefinite delivery contract, which provides pharmaceutical supply to Defense Health Agency medical facilities. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor for military healthcare supply.

Quick answers

Who was awarded contract SPE2DR26F92MN?

SPE2DR26F92MN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 11, 2026.

How much is contract SPE2DR26F92MN worth?

The government has obligated $57,487 on SPE2DR26F92MN.

Is contract SPE2DR26F92MN an order under another contract?

Yes. SPE2DR26F92MN is a delivery order under SPE2DR25D2103, an indefinite delivery contract.

Was contract SPE2DR26F92MN competed?

The extent of competition for SPE2DR26F92MN was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award